Literature DB >> 22130789

Influence of some formulation variables on the optimization of pH-dependent, colon-targeted, sustained-release mesalamine microspheres.

Ahmed Abd El-Bary1, Ahmed A Aboelwafa, Ibrahim M Al Sharabi.   

Abstract

The aim of this work was to understand the influence of different formulation variables on the optimization of pH-dependent, colon-targeted, sustained-release mesalamine microspheres prepared by O/O emulsion solvent evaporation method, employing pH-dependent Eudragit S and hydrophobic pH-independent ethylcellulose polymers. Formulation variables studied included concentration of Eudragit S in the internal phase and the ratios between; internal to external phase, drug to Eudragit S and Eudragit S to ethylcellulose to mesalamine. Prepared microspheres were evaluated by carrying out in vitro release studies and determination of particle size, production yield, and encapsulation efficiency. In addition, morphology of microspheres was examined using optical and scanning electron microscopy. Emulsion solvent evaporation method was found to be sensitive to the studied formulation variables. Particle size and encapsulation efficiency increased by increasing Eudragit S concentration in the internal phase, ratio of internal to external phase, and ratio of Eudragit S to the drug. Employing Eudragit S alone in preparation of the microspheres is only successful in forming acid-resistant microspheres with pulsatile release pattern at high pH. Eudragit S and ethylcellulose blend microspheres were able to control release under acidic condition and to extend drug release at high pH. The stability studies carried out at 40°C/75% RH for 6 months proved the stability of the optimized formulation. From the results of this investigation, microencapsulation of mesalamine in microspheres using blend of Eudragit S and ethylcellulose could constitute a promising approach for site-specific and controlled delivery of drug in colon.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130789      PMCID: PMC3299443          DOI: 10.1208/s12249-011-9721-z

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  32 in total

1.  Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment.

Authors:  G Frieri; M T Pimpo; G C Palumbo; L Onori; A Viscido; G Latella; B Galletti; G C Pantaleoni; R Caprilli
Journal:  Aliment Pharmacol Ther       Date:  1999-11       Impact factor: 8.171

2.  pH-sensitive Eudragit nanoparticles for mucosal drug delivery.

Authors:  Jin-Wook Yoo; Namita Giri; Chi H Lee
Journal:  Int J Pharm       Date:  2010-10-31       Impact factor: 5.875

3.  Control of encapsulation efficiency in polymeric microparticle system of tolmetin.

Authors:  Mitra Jelvehgari; Hadi Valizadeh; Majid Rezapour; Ali Nokhodchi
Journal:  Pharm Dev Technol       Date:  2010 Jan-Feb       Impact factor: 3.133

4.  Colon specific delivery of indomethacin: effect of incorporating pH sensitive polymers in xanthan gum matrix bases.

Authors:  Laila F A Asghar; Chetan B Chure; Sajeev Chandran
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

5.  Mechanistic analysis of drug release from theophylline pellets coated by films containing pectin, chitosan and Eudragit RS.

Authors:  Alireza Ghaffari; Mohammad Reza Avadi; Hamid Reza Moghimi; Mahvash Oskoui; Khosrow Bayati; Morteza Rafiee-Tehrani
Journal:  Drug Dev Ind Pharm       Date:  2008-04       Impact factor: 3.225

6.  Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: relevance to controlled intestinal drug delivery.

Authors:  D L French; J W Mauger
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

7.  Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.

Authors:  Mohamed A Alhnan; Abdul W Basit
Journal:  Eur J Pharm Sci       Date:  2010-10-13       Impact factor: 4.384

8.  The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles.

Authors:  Suchada Nilkumhang; Abdul W Basit
Journal:  Int J Pharm       Date:  2009-04-01       Impact factor: 5.875

9.  Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.

Authors:  Shahrzad Missaghi; Cara Young; Kurt Fegely; Ali R Rajabi-Siahboomi
Journal:  Drug Dev Ind Pharm       Date:  2010-02       Impact factor: 3.225

10.  Design and evaluation of matrices of Eudragit with polycarbophil and carbopol for colon-specific delivery.

Authors:  Laila Fatima Ali Asghar; Sajeev Chandran
Journal:  J Drug Target       Date:  2008-12       Impact factor: 5.121

View more
  2 in total

1.  Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers.

Authors:  Enas El-Maghawry; Mina I Tadros; Seham A Elkheshen; Ahmed Abd-Elbary
Journal:  Int J Nanomedicine       Date:  2020-06-08

2.  Maximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using Draper-Lin small composite design.

Authors:  Khalid Mohamed El-Say
Journal:  Drug Des Devel Ther       Date:  2016-02-24       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.